Skye Bioscience, Inc. (SKYE) Operating cash flow 2016–2025
Skye Bioscience, Inc. (SKYE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$43.1MFY2025 · since FY2016: -$3.6M → -$43.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.1M | -70.6% |
| FY2024 | -$25.2M | -80.9% |
| FY2023 | -$14.0M | -9.5% |
| FY2022 | -$12.7M | -96.8% |
| FY2021 | -$6.5M | -6.9% |
| FY2020 | -$6.1M | -0.4% |
| FY2019 | -$6.0M | -52.9% |
| FY2018 | -$3.9M | -18.4% |
| FY2017 | -$3.3M | +6.2% |
| FY2016 | -$3.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice